How do you sequence TAVR versus liver transplant listing in candidates with severe aortic stenosis and decompensated cirrhosis when MELD is rising—what clinical features most strongly favor accelerating TAVR versus deferring valve intervention?

The response to this is not straightforward, as the decision depends on the severity of AS and the patient's severity of liver disease and transplant candidacy. The decision involves Cardiology and the liver team. In severe AS, TAVR may be indicated with no other viable option. Intervention risk, fr...